Spinal nitric oxide contributes to the analgesic effect of intrathecal [D-Pen2, D-Pen5]-enkephalin in normal and diabetic rats

Anesthesiology

Volumn 98, Issue 1, 2003, Pages 217-222

  Chen, Shao Rui ^a   Pan, Hui Lin ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; ARGININE; DEXTRO ARGININE; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; STREPTOZOCIN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CATHETERIZATION; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOSE RESPONSE; FEMALE; HYPERALGESIA; NEUROPATHIC PAIN; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENZYME INHIBITORS; INJECTIONS, SPINAL; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; OMEGA-N-METHYLARGININE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037217640     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200301000-00033     Document Type: Article

References (45)

1. Boulton AJ, Malik RA: Diabetic neuropathy. Med Clin North Am 1998; 82:909-29
2. Clark CM Jr, Lee DA: Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995;332:1210-7
3. Wright JM: Review of the symptomatic treatment of diabetic neuropathy. Pharmacotherapy 1994;14:689-97
4. Arner S, Meyerson BA: Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988;33:11-23
5. Kamei J, Ohhashi Y, Aoki T, Kawasima N, Kasuya Y: Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists. Brain Res 1992;571:199-203
6. Zurek JR, Nadeson R, Goodchild CS: Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats. Pain 2001;90:57-63
7. Dickenson AH: Plasticity: Implications for opioid and other pharmacological interventions in specific pain states. Behav Brain Sci 1997;20:392-403
8. Cheng PY, Wu D, Decena J, Soong Y, McCabe S, Szeto HH: Opioid-induced stimulation of fetal respiratory activity by [D-Ala2]deltorphin I. Eur J Pharmacol 1993;230:85-8
9. Sheldon RJ, Riviere PJ, Malarchik ME, Moseberg HI, Burks TF, Porreca F: Opioid regulation of mucosal ion transport in the mouse isolated jejunum. J Pharmacol Exp Ther 1990;253:144-51
10. Cowan A, Zhu XZ, Mosberg HI, Omnaas JR, Porreca F: Direct dependence studies in rats with agents selective for different types of opioid receptor. J Pharmacol Exp Ther 1988;246:950-5
11. Maher CE, Eisenach JC, Pan HL, Xiao R, Childers SR: Chronic intrathecal morphine administration produces homologous mu receptor/G-protein desensitization specifically in spinal cord. Brain Res 2001;895:1-8
12. Drower EJ, Stapelfeld A, Rafferty MF, de Costa BR, Rice KC, Hammond DL: Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic [D-penicillamine2-D-penicillamine5]enkephalin in the rat. J Pharmacol Exp Ther 1991;259:725-31
13. Dickenson AH, Sullivan AF, Knox R, Zajac JM, Roques BP: Opioid receptor subtypes in the rat spinal cord: Electrophysiological studies with mu- and deltaopioid receptor agonists in the control of nociception. Brain Res 1987;413: 36-44
14. Heyman JS, Mulvaney SA, Mosberg HI, Porreca F: Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice. Brain Res 1987; 420:100-8
15. Laugwitz KL, Offermanns S, Spicher K, Schultz G: mu and delta opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron 1993;10:233-42
16. Offermanns S, Schultz G, Rosenthal W: Evidence for opioid receptor-mediated activation of the G-proteins, Go and Gi2, in membranes of neuroblastoma x glioma (NG108-15) hybrid cells. J Biol Chem 1991;266:3365-8
17. Reuss MH, Reuss S: Nitric oxide synthase neurons in the rodent spinal cord: Distribution, relation to substance P fibers, and effects of dorsal rhizotomy. J Chem Neuroanat 2001;21:181-96
18. Valtschanoff JG, Weinberg RJ, Rustioni A, Schmidt HH: Nitric oxide synthase and GABA colocalize in lamina II of rat spinal cord. Neurosci Lett 1992; 148:6-10
19. Song HK, Pan HL, Eisenach JC: Spinal nitric oxide mediates antinociception from intravenous morphine. Anesthesiology 1998;89:215-21
20. Chen SR, Khan GM, Pan HL: Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain. Anesthesiology 2001;95:1007-12
21. Kolesnikov YA, Pan YX, Babey AM, Jain S, Wilson R, Pasternak GW: Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: Evidence for opposing NO actions on morphine analgesia and tolerance. Proc Natl Acad Sci U S A 1997;94:8220-5
22. Christopoulos A, El-Fakahany EE: The generation of nitric oxide by G protein-coupled receptors. Life Sci 1999;64:1-15
23. Nozaki-Taguchi N, Yamamoto T: Involvement of nitric oxide in peripheral antinociception mediated by kappa- and delta-opioid receptors. Anesth Analg 1998;87:388-93
24. Calcutt NA, Chaplan SR: Spinal pharmacology of tactile allodynia in diabetic rats. Br J Pharmacol 1997;122:1478-82
25. Courteix C, Eschalier A, Lavarenne J: Streptozocin-induced diabetic rats: Behavioural evidence for a model of chronic pain. Pain 1993;53:81-8
26. Courteix C, Bardin M, Chantelauze C, Lavarenne J, Eschalier A: Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. Pain 1994;57:153-60
27. Chen SR, Pan HL: Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats. J Neurophysiol 2002;87:2726-733
28. Chen SR, Eisenach JC, McCaslin PP, Pan HL: Synergistic effect between intrathecal non-NMDA antagonist and gabapentin on allodynia induced by spinal nerve ligation in rats. Anesthesiology 2000;92:500-6
29. Hao JX, Yu W, Wiesenfeld-Hallin Z, Xu XJ: Treatment of chronic allodynia in spinally injured rats: Effects of intrathecal selective opioid receptor agonists. Pain 1998;75:209-17
30. Malmberg AB, Yaksh TL: Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: Effects of naltrindole and its benzofuran analog (NTB). J Pharmacol Exp Ther 1992;263:264-75
31. Handy RL, Harb HL, Wallace P, Gaffen Z, Whitehead KJ, Moore PK: Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: Antinociceptive and cardiovascular effects. Br J Pharmacol 1996; 119:423-31
32. Kurihara T, Yoshioka K: The excitatory and inhibitory modulation of primary afferent fibre-evoked responses of ventral roots in the neonatal rat spinal cord exerted by nitric oxide. Br J Pharmacol 1996;118:1743-53
33. Pan HL, Chen SR, Eisenach JC: Role of spinal NO in antiallodynic effect of intrathecal clonidine in neuropathic rats. Anesthesiology 1998;89:1518-23
34. Mosberg HI, Hurst R, Hruby VJ, Gee K, Yamamura HI, Galligan JJ, Burks TF: Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc Natl Acad Sci U S A 1983;80:5871-4
35. Mika J, Przewlocki R, Przewlocka B: The role of delta-opioid receptor subtypes in neuropathic pain. Eur J Pharmacol 2001;415:31-7
36. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques BP, Kieffer BL: Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 1996;383:819-23
37. Sora I, Funada M, Uhl GR: The mu-opioid receptor is necessary for [D-Pen(2.5)]enkephalin-induced analgesia. Eur J Pharmacol 1997; 324:R1-2
38. Fraser GL, Pradhan AA, Clarke PB, Wahlestedt C: Supraspinal antinociceptive response to [D-Pen(2.5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat. J Pharmacol Exp Ther 2000;295: 1135-41
39. He L, Lee NM: Delta opioid receptor enhancement of mu opioid receptorinduced antinociception in spinal cord. J Pharmacol Exp Ther 1998;285:1181-6
40. Chen SR, Sweigart KL, Lakoski JM, Pan HL: Functional mu opioid receptors are reduced in the spinal cord dorsal horn of diabetic rats. Anesthesiology 2002; 97:1602-8
41. Masue T, Dohi S, Asano T, Shimonaka H: Spinal antinociceptive effect of epidural nonsteroidal antiinflammatory drugs on nitric oxide-induced hyperalgesia in rats. Anesthesiology 1999;91:198-206
42. Meller ST, Cummings CP, Traub RJ, Gebhart GF: The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carrageenan in the rat. Neuroscience 1994;60:367-74
43. Yamamoto T, Shimoyama N: Role of nitric oxide in the development of thermal hyperesthesia induced by sciatic nerve constriction injury in the rat. Anesthesiology 1995;82:1266-73
44. Hoheisel U, Unger T, Mense S: A block of spinal nitric oxide synthesis leads to increased background activity predominantly in nociceptive dorsal horn neurones in the rat. Pain 2000;88:249-57
45. Chen SR, Eisenach JC, Pan HL: Intrathecal S-nitroso-N-acetylpenicillamine and L-cysteine attenuate nerve injury-induced allodynia through noradrenergic activation in rats. Neuroscience 2000;101:759-65